Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva Pharmaceutical upgraded to 'Buy' at UBS
Infographic: Teva Pharmaceuticals (TEVA) Q1 2020 earnings results | AlphaStreet
Teva Pharmaceuticals - Next generation supply chain transformation by digitalisation at Teva by iThink Media - Issuu
Teva Pharmaceutical Industries Ltd. | Facebook
Teva Pharmaceutical To Rally Around 58%? Here Are 10 Top Analyst Forecasts For Monday | Markets Insider
Teva settles price-fixing claims with State of Kentucky for $1.41M (NYSE: TEVA) | Seeking Alpha
Teva Pharmaceuticals USA, Inc., Issues Voluntary Nationwide Recall of Specific Lots of Fentanyl Buccal Tablets CII Because of Labeling Error | ONS Voice
Teva Pharma News, Teva Pharma Quote, TEVA Quote - StreetInsider.com
Teva CEO Kåre Schultz discusses company's latest quarter and opioid settlement - YouTube
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Eagle Pharma, Teva Pharma Diverge On 'Surprise' Leukemia Drug Win | Stock News & Stock Market Analysis - IBD
Teva Pharmaceutical Sets Aside $200 Million for Potential DOJ Settlement - Bloomberg
Teva Pharmaceuticals found liable in New York opioid trial
Teva Crashes Following Purdue Pharma $10-$12 Billion Settlement Reports | Ctech
Teva Pharma CEO Richard Francis on Q4 earnings
Teva Pharmaceutical posts rise in Q3 2023 net income to $80m
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
Opioid firm Teva agrees $85m settlement days before Oklahoma case goes to court | US News | Sky News
Pharma companies ask court not to break up US states' price-fixing lawsuits | Reuters
Teva Pharmaceuticals on LinkedIn: #pivottogrowth
Teva Pharma Appoints Novartis, Biogen Vet as New President and CEO | BioSpace
Teva weighs potential sale of its $2B API business: reports
Teva to pay New York $500M for role in opioid crisis - POLITICO
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
